Regeneron Pharmaceuticals Inc. (REGN)

Index:

Nasdaq 100

$ 588.82
   
  • Change Today:
    $-8.04
  • 52 Week High: $1,201.76
  • 52 Week Low: $571.06
  • Currency: US Dollars
  • Shares Issued: 107.80m
  • Volume: 295,424
  • Market Cap: $63,474m
  • RiskGrade: 129

Regeneron Pharmaceuticals Covid-19 antibodies 100% effective in blocking infections

By Alexander Bueso

Date: Tuesday 26 Jan 2021

LONDON (ShareCast) - (Sharecast News) - Regeneron Pharmaceuticals antibody cocktail severely curtails Covid-19 symptoms and infections, the results of a late-stage trial showed.

The trial involving 400 patients with at least one household member sick from Covid-19 showed that the two-antibody cocktail, known as REGEN-COV, completely cut symptomatic infections of the novel coronavirus.

Overall rates of infections meanwhile were reduced by approximately half.

A rival treatment from Eli Lilly, bamlanivimab, had shown a similar efficacy the week before, reducing Covid-19 infections among nursing home resident in a trial by 80%.

As of 1650 GMT, Regeneron shares had slipped 1.11% to $542.14.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

REGN Market Data

Currency US Dollars
Share Price $ 588.82
Change Today $ -8.04
% Change -1.35 %
52 Week High $1,201.76
52 Week Low $571.06
Volume 295,424
Shares Issued 107.80m
Market Cap $63,474m
RiskGrade 129

What The Brokers Say

Strong Buy 10
Buy 10
Neutral 5
Sell 1
Strong Sell 0
Total 26
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 23-May-2025

Time Volume / Share Price
12:56 100 @ $588.82
12:56 100 @ $588.82
12:55 100 @ $588.83
12:55 200 @ $588.82
12:55 100 @ $588.82

Top of Page